BHC251219P3000
- 0.29
- 0.000.00%
Bausch Health Newsroom
Bausch Health Companies Analyst Ratings
A Quick Look at Today's Ratings for Bausch Health(BHC.US), With a Forecast Between $3 to $12
RBC Lifts Price Target on Bausch Health to $11 From $10, Keeps Sector Perform Rating
Piper Sandler Maintains Bausch Health(BHC.US) With Sell Rating, Maintains Target Price $3
RBC Capital Maintains Bausch Health(BHC.US) With Hold Rating, Raises Target Price to $10
Evercore Maintains Bausch Health(BHC.US) With Hold Rating
Evercore ISI Reaffirms Their Hold Rating on Bausch Health Companies (BHC)
Jefferies Maintains Bausch Health(BHC.US) With Buy Rating, Raises Target Price to $10
Jefferies Maintains Bausch Health(BHC.US) With Buy Rating, Cuts Target Price to $9
Bausch Health Companies Inc. Price Target Cut to $9.00/Share From $13.00 by Jefferies & Co
TD Cowen Maintains Bausch Health(BHC.US) With Hold Rating, Maintains Target Price $12
Bausch Health: A Balanced Hold Amid Revenue Growth and Operational Challenges
Bausch Health Companies Inc. Price Target Cut to $8.50/Share From $10.00 by Scotiabank
A Quick Look at Today's Ratings for Bausch Health(BHC.US), With a Forecast Between $3 to $8.5
Bausch Health Companies Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Bausch Health Companies (BHC) and Neurocrine (NBIX)
Jefferies Maintains Bausch Health(BHC.US) With Buy Rating, Cuts Target Price to $13
Bausch Health Companies Analyst Ratings
Truist Financial Maintains Bausch Health(BHC.US) With Hold Rating, Maintains Target Price $8
Truist Financial Maintains Bausch Health(BHC.US) With Hold Rating, Announces Target Price $8